BioCentury
ARTICLE | Financial News

Agile sets IPO range

May 10, 2014 1:54 AM UTC

Contraceptive play Agile Therapeutics Inc. (Princeton, N.J.) amended its IPO on NASDAQ and now plans to sell 4.6 million shares at $12-$14. At the $13 midpoint, the company would raise $60 million and be valued at $180.5 million. RBC Capital Markets; William Blair; Cantor Fitzgerald; and Janney Montgomery Scott are underwriters. Agile filed to raise up to $69 million in the offering in March. ...